18 years or older

English speaking/reading/writing

Breast cancer stages I through III

Any performance status suitable for chemotherapy as determined by the physician

Primary or secondary chemotherapy, but enrolling patients prior to a chemotherapy regimen regardless of previous radiation therapy exposure and/or previous mastectomy.

Scheduled to receive either of the following two regimens:

Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (175 mg/m2)

Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (80 g/m2)

Taxotere (75mg/m2), Cytoxan (600 mg/m2)

Taxotere (75 mg/m2), Carboplatin (AUC 6), Perjeta (840 mg loading fixed dose, followed by 420 mg maintenance fixed dose)

The Efficacy of Acupuncture in Treating Chemotherapy Side Effects in Breast Cancer Patients

What this study is about